Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

Crossref

1. Sofosbuvir-Containing Regimen for the Treatment of Hepatitis C Virus in a Patient With Sickle-Thalassemia: The First Case Report

- Nawfal R Hussein

2. Treatment of Chronic HCV in Special Populations: Thalassemia, Hemophilia, and Hemodialysis Patients

- Seyed Moayed Alavian

- Kamran Bagheri Lankarani

- Ala I. Sharara

3. Cost-Effectiveness Analysis of Adding Low Dose Ribavirin to Peginterferon Alfa-2a for Treatment of Chronic Hepatitis C Infected Thalassemia Major Patients in Iran

- Alireza Mehrazmay

- Seyed-Moayed Alavian

- Maziar Moradi-Lakeh

- Mahdi Mokhtari Payam

- Amir Hashemi-Meshkini

- Bita Behnava

- Seyyed Mohammad Miri

- Pegah Karimi Elizeh

- Seyed Vahid Tabatabaee

- Maryam Keshvari

- Kamran Bagheri Lankarani

4. The treatment of HCV in patients with haemoglobinopathy in Kurdistan Region, Iraq: a single centre experience

- N. R. HUSSEIN

- I. TUNJEL

- Z. BASHARAT

- A. TAHA

- W. IRVING

5. Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013

- Nasser Ebrahimi Daryani

- Seyed Moayed Alavian

- Mohammad Hossein Somi

- Mohammad Torabi-Nami

6. Burden of Hepatitis C on Patients with Thalassemia

- Zahra Sepehri

- Seyed Moayed Alavian

7. Burden of Hepatitis C on Patients with Thalassemia

- Zahra Sepehri

- Seyed Moayed Alavian

8. The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C

- Bita Behnava

- Heidar Sharafi

- Maryam Keshvari

- Ali Pouryasin

- Leila Mehrnoush

- Shima Salimi

- Pegah Karimi Elizee

- Mehran Ghazimoghaddam

- Seyed Moayed Alavian

9. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India

- Pankaj Puri

- Anil C. Anand

- Vivek A. Saraswat

- Subrat K. Acharya

- Shiv K. Sarin

- Radha K. Dhiman

- Rakesh Aggarwal

- Shivaram P. Singh

- Deepak Amarapurkar

- Anil Arora

- Mohinish Chhabra

- Kamal Chetri

- Gourdas Choudhuri

- Vinod K. Dixit

- Ajay Duseja

- Ajay K. Jain

- Dharmesh Kapoor

- Premashis Kar

- Abraham Koshy

- Ashish Kumar

- Kaushal Madan

- Sri P. Misra

- Mohan V.G. Prasad

- Aabha Nagral

- Amarendra S. Puri

- R. Jeyamani

- Sanjiv Saigal

- Samir Shah

- Praveen K. Sharma

- Ajit Sood

- Sandeep Thareja

- Manav Wadhawan

10. WITHDRAWN: Efficacy and Side Effects of Sofosbuvir and Daclatasvir for Treatment of Hepatitis C in Thalassemia Major Patients with Treatment Experience of Interferon-Based Regimens

- Jamshid Vafaeimanesh

- Fahimeh Safarnezhad Tameshkel

- Hossein Ajdarkosh

- Azita Azarkeyvani

- Mahmoodreza Khoonsari

- Amirhossein Faraji

- Masoudreza Sohrabi

- Sima Aten

- Hossein Keyvani

- Farhad Zamani

11. Hepatitis C Virus Treatment in Non-Liver Organ Transplantation Programs

- Eduardo A. Rodriguez

- Bashar A. Aqel

12. Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy

- Saleh Sandoughdaran

- Seyed Moayed Alavian

- Heidar Sharafi

- Bita Behnava

- Shima Salimi

- Leila Mehrnoush

- Maryam Keshvari

13. The Effectiveness of Sofosbuvir and Daclatasvir in the Treatment of Hepatitis C in Thalassaemia Major Patients and their Effect on Haematological Factors

- Farhad Zamani

- Hossein Ajdarkosh

- Fahimeh Safarnezhad-Tameshkel

- Azita Azarkeivan

- Hossein Keyvani

- Farshad Naserifar

- Jamshid Vafaeimanesh

14. Long-Term Follow-Up of Thalassemia Major Patients with Hepatitis C Virus Treated with Sofosbuvir and Daclatasvir: A Cohort Study

- Fahimeh Safarnezhad Tameshkel

- Mohammad Hadi Karbalaie Niya

- Bahareh Amirkalali

- Nima Motamed

- Jamshid Vafaeimanesh

- Mansooreh Maadi

- Masodreza Sohrabi

- Amir Hossein Faraji

- Mahmoodreza Khoonsari

- Hossein Ajdarkosh

- Mehdi Nikkhah

- Elham Sobh Rakhashankhah

- Farhad Zamani

15. Safety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled Trials

- Ehsan Aminizadeh

- Seyed Moayyed Alavian

- Ali Akbari Sari

- Nasser Ebrahimi Daryani

- Bita Behnava

16. The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C

- Po-Cheng Liang

- Pei-Chin Lin

- Ching-I. Huang

- Chung-Feng Huang

- Ming-Lun Yeh

- Yu-Sheng Zeng

- Wan-Yi Hsu

- Ming-Yen Hsieh

- Zu-Yau Lin

- Shinn-Cherng Chen

- Jee-Fu Huang

- Chia-Yen Dai

- Wan-Long Chuang

- Shyh-Shin Chiou

- Ming-Lung Yu

17. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals

- Khashayar Hesamizadeh

- Heidar Sharafi

- Mohammad Saeid Rezaee-Zavareh

- Bita Behnava

- Seyed Moayed Alavian